BioCentury
ARTICLE | Company News

Avanir, Novartis neurology news

September 2, 2013 7:00 AM UTC

Avanir and Novartis' Sandoz generics division settled a May suit alleging Sandoz's ANDA for a generic version of Nuedexta dextromethorphan/quinidine to treat pseudobulbar affect (PBA) infringes Avani...